Research programme: selective 5-HT1B/D antagonists and inverse agonists - Pfizer
Latest Information Update: 16 Jul 2016
At a glance
- Originator Pfizer
- Class Piperazines
- Mechanism of Action Serotonin 1B receptor antagonists; Serotonin 1B receptor inverse agonists; Serotonin 1D receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Major depressive disorder in USA (PO)
- 17 Apr 2008 Early research in Depression in USA (PO)